TJ-M2010-5, A self-developed MyD88 inhibitor, attenuates liver fibrosis by inhibiting the NF-κB pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TJ-M2010-5, A self-developed MyD88 inhibitor, attenuates liver fibrosis by inhibiting the NF-κB pathway

Published:2022-02 Issue: Volume:354 Page:109839
ISSN:0009-2797
Container-title:Chemico-Biological Interactions
language:en
Short-container-title:Chemico-Biological Interactions

Author:

Xie Yalong,Du Dunfeng,Zhang Limin,Yang Yang,Zou Zhimiao,Li Zeyang,Zhou Liang,Shang Runshi,Zhou Ping

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference43 articles.

1. Liver inflammation and fibrosis;Koyama;J. Clin. Invest.,2017

2. Liver fibrosis: mechanistic concepts and therapeutic perspectives;Roehlen;Cells,2020

3. PLK1 regulates hepatic stellate cell activation and liver fibrosis through Wnt/beta-catenin signalling pathway;Chen;J. Cell Mol. Med.,2020

4. Chronic liver diseases and liver cancer: an update in 2015;Kudo;Dig. Dis.,2015

5. Hepatic fibrosis: concept to treatment;Trautwein;J. Hepatol.,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MyD88 and Its Inhibitors in Cancer: Prospects and Challenges;Biomolecules;2024-05-07

2. Innate immune modulation in transplantation: mechanisms, challenges, and opportunities;Frontiers in Transplantation;2023-12-08

3. Integration of MyD88 inhibitor into mesoporous cerium oxide nanozymes-based targeted delivery platform for enhancing treatment of ulcerative colitis;Journal of Controlled Release;2023-09

4. Expression and Function of BMP and Activin Membrane-Bound Inhibitor (BAMBI) in Chronic Liver Diseases and Hepatocellular Carcinoma;International Journal of Molecular Sciences;2023-02-09

5. Interleukin-19 upregulates fibronectin and collagen I expression via the NF-κB-Smad2/3 pathway in fibroblasts of patients with chronic rhinosinusitis;Inflammation Research;2022-11-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3